TivirapineAlternative Names: R 86183
Latest Information Update: 30 Aug 2001
Price : $50
At a glance
- Originator Janssen L.P.
- Class Antiretrovirals
- Mechanism of Action RNA-directed DNA polymerase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV-1 infections
Most Recent Events
- 30 Aug 2001 No-Development-Reported for HIV-1 infections in USA (Unknown route)
- 30 Aug 2001 No-Development-Reported for HIV-1 infections in Belgium (Unknown route)
- 13 Jun 1997 Phase-I clinical trials for HIV-1 infections in Belgium (Unknown route)